ARCHIVES

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

This article is from The Cancer Letter archive.

Vol. 03 No. 40 | October 7, 1977

Download PDF Visit The Full Archive

Related Articles

Artificial Neural Networks Predict Clinical Outcomes

November 26, 2004

Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia

May 25, 2007

ORI finds Hopkins Coordinator Falsified Information On Grant

May 16, 1997

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

Vogel To Succeed Yates As VP for Research At American Cancer Society.

October 17, 2008

In Brief: Univ. of New Mexico Looked Over As Possible Comprehensive Center; Missouri Asks Delay

November 26, 1976